| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086031 Inhibition Of The Activity Of The Capsaicin Receptor In The Treatment Of Obesity Or Obesity-Related Diseases And Disorders |
| 04/14/2011 | US20110086028 Prevention of hiv infection |
| 04/14/2011 | US20110086021 Sclerostin and the inhibition of WNT signaling and bone formation |
| 04/14/2011 | US20110086018 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 04/14/2011 | US20110086017 Medical Food composition and methods for management of inflammatory processes in mammals |
| 04/14/2011 | US20110086016 Enzymatic pre-mixture against Gram negative bacteria colonization in the animal intestinal tract |
| 04/14/2011 | US20110086015 Zinc finger nuclease for the cftr gene and methods of use thereof |
| 04/14/2011 | US20110086014 Method for enzymatic cross-linking of a protein |
| 04/14/2011 | US20110086013 Acylglycerol acetyltransferase-like protein mgat-x1 and uses thereof |
| 04/14/2011 | US20110086011 Prevention or Treatment of Immune-Relevant Disease by Modification of Microfloral Populations |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/14/2011 | US20110086005 Modulating interstitial pressure and oncolytic viral delivery and distribution |
| 04/14/2011 | US20110086004 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/14/2011 | US20110086003 Stabilization of hydrophobic protein therapeutic agents |
| 04/14/2011 | US20110086002 Restoration of hearing loss |
| 04/14/2011 | US20110085989 Novel antimicrobial peptides |
| 04/14/2011 | US20110085986 Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides |
| 04/14/2011 | US20110083987 Methods and compositions for tissue regeneration |
| 04/14/2011 | CA2813494A1 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences |
| 04/14/2011 | CA2777237A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 04/14/2011 | CA2777222A1 Il-17 family cytokine compositions and uses |
| 04/14/2011 | CA2777198A1 Use of toll-like receptor and agonist for treating cancer |
| 04/14/2011 | CA2776964A1 The intestine and muscle recovery |
| 04/14/2011 | CA2776874A1 Chaperonin 10 variants |
| 04/14/2011 | CA2776790A1 Pharmaceutical preparation comprising recombinant hcg |
| 04/14/2011 | CA2776613A1 Devices, systems and methods for cell modification |
| 04/14/2011 | CA2776581A1 Methods for the prevention or treatment of heart failure |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
| 04/13/2011 | EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 04/13/2011 | EP2308981A1 Streptococcal C5a peptidase vaccine |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308967A1 Cleavage of VEGF and VEGF receptor by wildtype and mutant MT-SP1 |
| 04/13/2011 | EP2308963A2 System for processing lipoaspirate cells |
| 04/13/2011 | EP2308896A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 04/13/2011 | EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors |
| 04/13/2011 | EP2308507A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/13/2011 | EP2308503A1 Method to increase the development of livestock |
| 04/13/2011 | EP2308502A1 Method to induce neovascular formation and tissue regeneration |
| 04/13/2011 | EP2308501A1 Platelet-derived growth factor compositions and methods of use thereof |
| 04/13/2011 | EP2308500A1 Platelet-derived growth factor compositions and methods of use thereof |
| 04/13/2011 | EP2308479A2 Compounds and compositions for delivering active agents |
| 04/13/2011 | EP2308473A1 Pharmaceutical composition containing surface-coated microparticles |
| 04/13/2011 | EP2307542A1 Method for treating or preventing radiation damage by in vivo gene therapy |
| 04/13/2011 | EP2307450A1 Enamel matrix derivative fraction c |
| 04/13/2011 | EP2307447A2 Natriuretic polypeptides with unique pharmacologic profiles |
| 04/13/2011 | EP2307446A1 Nonimmunosuppressive cyclosporine analogue molecules |
| 04/13/2011 | EP2307090A2 Method and system for recording and promoting peripheral nerve regeneration |
| 04/13/2011 | EP2307046A2 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/13/2011 | EP2307045A1 Methods and compositions |
| 04/13/2011 | EP2307044A1 Orally administrable dosage forms comprising angiogenin and uses thereof |
| 04/13/2011 | EP2307043A1 Cd5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin |
| 04/13/2011 | EP2307042A2 Modulation of the trpv : vps10p-domain receptor system for the treatment of pain |
| 04/13/2011 | EP2307041A2 Dosing regimen |
| 04/13/2011 | EP2307040A1 Method and means for treating viral disease, in particular hiv/aids |
| 04/13/2011 | EP2307039A2 Opiorphin for use as a psychostimulant agent |
| 04/13/2011 | EP2307038A2 Therapeutic agents comprising elastin-like peptides |
| 04/13/2011 | EP2307037A1 Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers |
| 04/13/2011 | EP2307036A1 Novel peptide adjuvant for influenza vaccination |
| 04/13/2011 | EP2307035A2 Treatment for epilepsy |
| 04/13/2011 | EP2306985A2 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 04/13/2011 | EP2306823A1 Formulations of 5-fluorocytosine and uses thereof |
| 04/13/2011 | EP2069392B1 Tnf superfamily fusion proteins |
| 04/13/2011 | EP1759001B1 Bone delivery conjugates and method of using same to target proteins to bone |
| 04/13/2011 | EP1575605B1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser |
| 04/13/2011 | EP1572127B1 Enzyme treatment of foodstuffs for celiac sprue |
| 04/13/2011 | EP1558640B1 Trimeric binding proteins for trimeric cytokines |
| 04/13/2011 | EP1549677B1 FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY |
| 04/13/2011 | EP1458749B1 Bone polypeptide-1 |
| 04/13/2011 | EP1425296B1 Organic compounds with biological activity as thrombin inhibitors and use thereof |
| 04/13/2011 | EP1181044B1 IMMOBILIZED LACTOFERRIN ( i Im /i -LF) ANTIMICROBIAL AGENTS AND USES THEREOF |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | EP0957941B1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 04/13/2011 | EP0889735B1 Immunological methods for the treatment of gastrointestinal cancer |
| 04/13/2011 | CN1993116B Use of discharge protein inhibitors in preparing medicine for improving bioavailability of a renin inhibitor |
| 04/13/2011 | CN1980690B Malignant tumor local infiltration inhibitor containing batroxobin |
| 04/13/2011 | CN1956726B Composition and method for releasing mammal inflammation and oxidation stress |
| 04/13/2011 | CN1950103B Application of growth hormone C-end fragment in pharmacy |
| 04/13/2011 | CN1910456B Marker for neuromyelitis optica |
| 04/13/2011 | CN1823088B Novel peptides that bind to the erythropoietin receptor |
| 04/13/2011 | CN1822851B Stable analogs of peptide and polypeptide therapeutics |
| 04/13/2011 | CN1780635B Preventives or remedies for hepatopathy |
| 04/13/2011 | CN1768873B Apparatus and method for electroporation mediated delivery for drugs and genes |
| 04/13/2011 | CN1763097B Polypeptide variants with altered effector function |
| 04/13/2011 | CN1759123B Uses of IL-23 agonists and antagonists, related reagents |
| 04/13/2011 | CN1688883B Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 04/13/2011 | CN1665488B Direct cellular energy delivery system |
| 04/13/2011 | CN102015772A Compositions and methods for inhibiting shiga toxin and shiga-like toxin |
| 04/13/2011 | CN102015764A Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 04/13/2011 | CN102015763A Affinity matured CRIg variants |
| 04/13/2011 | CN102015761A GLP-1 peptide having sugar chain attached thereto |
| 04/13/2011 | CN102015760A Methods and compositions using KLOTHO-FGF fusion polypeptides |
| 04/13/2011 | CN102015759A Use of defensins against tuberculosis |
| 04/13/2011 | CN102015758A Oligopeptidic compounds and uses thereof |
| 04/13/2011 | CN102015757A Modified Cpn10 and PRR signalling |
| 04/13/2011 | CN102015753A Hydrophobic modified preS-derived peptides of hepatitis b virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver |
| 04/13/2011 | CN102015751A Process to produce fibrillar proteins and method of treating using fibrillar proteins |
| 04/13/2011 | CN102014977A Compositions and methods for distraction osteogenesis |
| 04/13/2011 | CN102014951A Sustained release poloxamer containing pharmaceutical compositions |